LivaNova: Epilepsy trials

The registry lists 17 Epilepsy studies with LivaNova as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 4 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)CompletedNCT01846741Not applicableResults posted
• Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy PatientsTerminatedNCT00522418Phase 4Results posted
• IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.TerminatedNCT05975931
• Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK.TerminatedNCT04779814
• XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)WithdrawnNCT04282681
• Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.CompletedNCT03529045
• Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility StudyCompletedNCT03446664Not applicable
• Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement DataCompletedNCT01626599Not applicable
• 3-Dimensional Accelerometer Sub-StudyCompletedNCT01612689Not applicable
• ECG Vector DeterminationCompletedNCT01486056
• Physiological and Biomechanical Data Collection Study in Epilepsy SubjectsCompletedNCT01485016
• Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients StimulatedCompletedNCT01281293
• PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1CompletedNCT01281280
• Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With EpilepsyCompletedNCT01214707
• Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without EpilepsyCompletedNCT01202682
• Heart Rate Changes in Subjects With EpilepsyCompletedNCT01202669
• Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial SeizuresTerminatedNCT00215215Phase 4